Pfizer Launches Final Study For COVID Drug That’s Suspiciously Similar To ‘Horse Paste’
Another piece US anti-Ivermectin puzzle may have emerged. On Monday, Pfizer announced that it’s launching an accelerated Phase 2/3 trial for a COVID prophylactic pill designed to ward off COVID in those may have come in contact with the disease.
